Publication:
ACE2 in male genitourinary and endocrine systems: Does COVID-19 really affect these systems?

Thumbnail Image
Files
Xu-38-261-272-2023.pdf(1.12 MB)
Date
2023
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Xu, Chen Shuo ; Yang, Wan Xi
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-510
item.page.type
info:eu-repo/semantics/article
Description
Abstract
The virus that causes COVID-19 (Corona Virus Disease 2019), SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), is causing a worldwide pandemic, posing a substantial threat to human health. Patients show signs of pneumonia, ARDS, shock, acute cardiac injury, acute kidney injury and other complications. The SARS-CoV-2 receptor is angiotensin converting enzyme 2 (ACE2), which is an important component of the renin-angiotensin system (RAS). In addition, TMPRSS2 or other cofactors are needed to allow the virus to enter the host. Clinical patients have exhibited varying degrees of genitourinary and endocrine system damage, and some studies have also reported potential risks to the genitourinary and endocrine systems. This article reviews the mechanism underlying SARS-CoV-2 infection and the current studies on the male genitourinary and endocrine systems and proposes that more attention should be directed towards human reproductive and endocrine health during the SARS-CoV-2 epidemic.
publication.page.subject
COVID-19 , SARS-CoV-2 , ACE2 , Male genitourinary system , Endocrine system
Citation
Histology and Histopathology Vol. 38, nº3 (2023)
URI
http://hdl.handle.net/10201/129466
item.page.embargo
Collections
Histology and histopathology Vol.38, nº3 (2023)
Ir a Estadísticas